Cassava Sciences, Inc. (SAVA)
2.055
+0.02
(+1.23%)
USD |
NASDAQ |
Feb 09, 16:00
2.045
-0.01
(-0.49%)
After-Hours: 20:00
Cassava Sciences EPS Diluted (Quarterly) : -0.2237 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| cbdMD, Inc. | -0.0762 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Amicus Therapeutics, Inc. | 0.0558 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Ovid Therapeutics, Inc. | -0.171 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.81M |
| Total Expenses (Quarterly) | 10.81M |
| Enterprise Value | -8.015M |
| Earnings Yield | -107.0% |
| Normalized Earnings Yield | -106.95 |